AstraZeneca enabling precision diagnostics across Asia
About this episode
Michelle Martin discusses the impact of digital diagnostics on cancer treatment with Arun Krishna from AstraZeneca.
Two people with the same cancer diagnosis might actually need completely different treatments. Here is where digital diagnostics can make a difference. Michelle Martin speaks with Arun Krishna, Area Vice President, Asia at AstraZeneca, about why diagnostic gaps remain a major challenge across the region and where AI can step in. On Live Well with Michelle, listen for a fascinating discussion on how digital diagnostics could reshape the future of healthcare in this part of the world See omnystudio.com/listener for privacy information.
More episodes of Live Well with Michelle
- Market View: Lululemon Plunges, S-REITs vs Banks, Nvidia’s $13B AI Bet & Why the Dutch Are Moving Gold
- Advanced Diagnostic Tests the Super Health-Conscious are opting for
- Money and Me: BTO Ceiling at $16K, More Homes Coming: Is Singapore Turning Into a Buyer’s Market?
- Market View: Is Singapore Still the World’s Busiest Port? Plus, Is the AI Data Centre Boom Running Into a Lending Wall?
- Money and Me: Higher Rates and Investors Positioning
- Market View: Musk vs Altman Escalates, ComfortDelGro’s Copenhagen Win & Is the Fed About to Hike?
Explore listener stats, chart rankings, contacts and more on the Live Well with Michelle podcast page.